EVOME MEDICAL TECHNOLOGIES INC. Quarterly Cost of Revenue in CAD from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: CAD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Evome Medical Technologies Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2020 to Q4 2023.
  • Evome Medical Technologies Inc. Cost of Revenue for the quarter ending December 31, 2023 was CA$10.2M, a 44.4% increase year-over-year.
  • Evome Medical Technologies Inc. Cost of Revenue for the twelve months ending December 31, 2023 was CA$40.1M, a 49.5% increase year-over-year.
  • Evome Medical Technologies Inc. annual Cost of Revenue for 2023 was CA$40.1M.
  • Evome Medical Technologies Inc. annual Cost of Revenue for 2021 was CA$12.4M.
Cost of Revenue, Trailing 12 Months (CAD)
Cost of Revenue, Quarterly (CAD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 40.1M 10.2M +3.13M +44.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 37M 12.4M +4.54M +58% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 32.4M 10.9M +4.46M +68.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 28M 6.59M +1.15M +21.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 26.8M 7.05M +3.43M +94.6% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 23.4M 7.84M +5.07M +183% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 18.3M 6.48M +6.1M +1591% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 12.2M 5.44M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 3.62M +3.62M Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 2.77M +2.77M Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-17
Q2 2021 383K Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
Q4 2020 0 Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-14
Q3 2020 0 Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.